Modified bacteria convert plastic waste into pain reliever

Scientists have achieved a groundbreaking feat by genetically modifying E. coli bacteria to transform plastic waste into acetaminophen, the active ingredient in many over-the-counter pain relievers. This innovative process begins with breaking down plastic into its basic components, which the engineered bacteria then convert into the valuable pharmaceutical compound. This method not only addresses the global plastic waste problem but also provides a sustainable approach to drug manufacturing. The research, conducted by a team of biotechnologists, demonstrated an impressive conversion rate, with 92 percent of the degraded plastic being successfully turned into acetaminophen. This high efficiency showcases the potential of synthetic biology in tackling environmental issues while simultaneously contributing to the pharmaceutical industry. The approach could significantly reduce the reliance on traditional methods of drug production, which often involve petroleum-based resources. This development marks a significant step forward in the field of waste management and pharmaceutical production. By repurposing plastic waste, the technology offers a dual benefit: reducing environmental pollution and creating a new, sustainable source of a widely used medication. As the world grapples with mounting plastic waste and the need for sustainable practices, this innovation could pave the way for future advancements in circular economy solutions.

— Authored by Next24 Live